InsiderClue
← All stocks

EXOZYMES INC.

EXOZ Net buying
CIK 0002010788 #4617 in the set updated 17 Sep 2026
Bought (120 mo)
$59.40K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$15.42K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$15.42K
2 of 2 sales
Net
+$43.98K
+$43.98K against sales at will

By person

6 insiders · 13 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Heltzen Michael
Chief Executive Officer
$59.40K (9)
—
+$59.40K
14,453
0.1557%
$109.84K
—
Korman Tyler Paz
Chief Scientific Officer
—
$15.42K (2)
−$15.42K
762,837
8.22%
$5.80M
+5.5%
MDB Capital Holdings, LLC entity
10% owner
—
—
—
3,931,133
42.36%
$29.88M
+3.2%
Opgenorth Paul Hideo
Vice President, Development
—
—
—
645,149
6.95%
$4.90M
+1.5%
Perriman Damien Alan
Chief Commercial Officer
—
—
—
28,499
0.3071%
$216.59K
—
Nawaz Fouad
Vice President- Finance
—
—
—
9,488
0.1022%
$72.11K
—

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
Heltzen Michael
26 Aug 2026
Chief Executive Officer
Buy
250
$7.60
$1.90K
Heltzen Michael
26 Aug 2026
Chief Executive Officer
Buy
251
$7.35
$1.84K
Heltzen Michael
26 Aug 2026
Chief Executive Officer
Buy
4
$7.58
$30.32
Heltzen Michael
25 Aug 2026
Chief Executive Officer
Buy
100
$7.50
$750.00
Heltzen Michael
25 Aug 2026
Chief Executive Officer
Buy
250
$7.52
$1.88K
Heltzen Michael
2 Jul 2025
Chief Executive Officer
Buy
1,040
$10.22
$10.63K
Heltzen Michael
17 Jan 2025
Chief Executive Officer
Buy
1,767
$10.78
$19.05K
Heltzen Michael
16 Jan 2025
Chief Executive Officer
Buy
121
$10.72
$1.30K
Heltzen Michael
15 Nov 2024
Chief Executive Officer
Buy
1,984
$11.10
$22.02K
Show all 13 transactions →

What was left out

Form 4 filings counted 18
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 282,863
History held since 18 Nov 2024